AU1549701A - Novel transcription factor and dna thereof - Google Patents

Novel transcription factor and dna thereof

Info

Publication number
AU1549701A
AU1549701A AU15497/01A AU1549701A AU1549701A AU 1549701 A AU1549701 A AU 1549701A AU 15497/01 A AU15497/01 A AU 15497/01A AU 1549701 A AU1549701 A AU 1549701A AU 1549701 A AU1549701 A AU 1549701A
Authority
AU
Australia
Prior art keywords
present
dna
polypeptide
activity
preventives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15497/01A
Other languages
English (en)
Inventor
Yuichi Hikichi
Kenichi Noguchi
Koji Yoshimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU1549701A publication Critical patent/AU1549701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU15497/01A 1999-11-26 2000-11-24 Novel transcription factor and dna thereof Abandoned AU1549701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/336475 1999-11-26
JP33647599 1999-11-26
PCT/JP2000/008257 WO2001038392A1 (fr) 1999-11-26 2000-11-24 Nouveau facteur de transcription et son adn

Publications (1)

Publication Number Publication Date
AU1549701A true AU1549701A (en) 2001-06-04

Family

ID=18299528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15497/01A Abandoned AU1549701A (en) 1999-11-26 2000-11-24 Novel transcription factor and dna thereof

Country Status (8)

Country Link
US (1) US7241860B1 (enExample)
EP (1) EP1233023B1 (enExample)
JP (1) JP2001211890A (enExample)
AT (1) ATE286911T1 (enExample)
AU (1) AU1549701A (enExample)
CA (1) CA2392351A1 (enExample)
DE (1) DE60017453T2 (enExample)
WO (1) WO2001038392A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05178896A (ja) 1990-08-23 1993-07-20 Mitsubishi Kasei Corp 新規なタンパク質、それをコードする遺伝子及びその産生方法
JP3585180B2 (ja) * 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
US5851775A (en) * 1997-03-20 1998-12-22 Johns Hopkins University β-catenin, Tcf-4, and APC interact to prevent cancer

Also Published As

Publication number Publication date
ATE286911T1 (de) 2005-01-15
US7241860B1 (en) 2007-07-10
EP1233023A1 (en) 2002-08-21
DE60017453T2 (de) 2005-12-22
JP2001211890A (ja) 2001-08-07
CA2392351A1 (en) 2001-05-31
WO2001038392A1 (fr) 2001-05-31
EP1233023B1 (en) 2005-01-12
DE60017453D1 (de) 2005-02-17
EP1233023A4 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
AU1367095A (en) Effector proteins of rapamycin
AP0202538A0 (en) Inhibitors of interleukin -1b converting enzyme.
IL143266A0 (en) Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same
AU2633497A (en) Peptides having antiproliferative properties
AU1615599A (en) Differentiation of adipose stromal cells into osteoblasts and uses thereof
WO2001051006A3 (en) Cardiac-cell specific enhancer elements and uses thereof
IL136738A0 (en) Inhibition of p38 kinase activity using substituted heterocyclic ureas
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
AU2984700A (en) Injectable collagen-based delivery system for bone morphogenic proteins
DE69819360D1 (de) Neue psoralene zur inaktivierung von pathogenen
WO1999037604A3 (en) Dialkyl ureas as calcitonin mimetics
AU2707797A (en) Methods and means for inhibition of cdk4 activity
WO1998058911A3 (en) Prostaglandin agonists
AU6704794A (en) Protection of human bone marrow from high dose antifolate therapy using mutated human dihydrofolate reductase dna
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
AU6245898A (en) Injectable formulations for treatment of osteoporotic bone
ZA9711580B (en) Process for the production of purified dimeric bone morphogenetic factors.
ATE266396T1 (de) Zubereitung und verwendung von rar antagonisten zur forderung der chondrogenese
AU1549701A (en) Novel transcription factor and dna thereof
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
AU550390B2 (en) Mitogens of leukocytes
ZA966953B (en) Pharmaceutical composition.
AU6346898A (en) Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters
IL151211A0 (en) Compositions useful for regulating parkin gene activity
CA2175368A1 (en) Proliferation antagonistic inhibitor of mesenchymal cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase